GO:0004854 | xanthine dehydrogenase activity | 2.63% (2/76) | 8.42 | 1.1e-05 | 0.003485 |
GO:0004855 | xanthine oxidase activity | 2.63% (2/76) | 8.42 | 1.1e-05 | 0.003485 |
GO:0046713 | borate transport | 3.95% (3/76) | 6.13 | 1.1e-05 | 0.005504 |
GO:0140375 | immune receptor activity | 3.95% (3/76) | 6.13 | 1.1e-05 | 0.005504 |
GO:0016727 | oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor | 2.63% (2/76) | 8.01 | 2.2e-05 | 0.005802 |
GO:0006147 | guanine catabolic process | 2.63% (2/76) | 7.42 | 5.6e-05 | 0.006677 |
GO:0009114 | hypoxanthine catabolic process | 2.63% (2/76) | 7.42 | 5.6e-05 | 0.006677 |
GO:0009115 | xanthine catabolic process | 2.63% (2/76) | 7.42 | 5.6e-05 | 0.006677 |
GO:0046100 | hypoxanthine metabolic process | 2.63% (2/76) | 7.42 | 5.6e-05 | 0.006677 |
GO:0046110 | xanthine metabolic process | 2.63% (2/76) | 7.42 | 5.6e-05 | 0.006677 |
GO:0016726 | oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor | 2.63% (2/76) | 7.68 | 3.7e-05 | 0.007243 |
GO:0042554 | superoxide anion generation | 2.63% (2/76) | 7.68 | 3.7e-05 | 0.007243 |
GO:0009172 | purine deoxyribonucleoside monophosphate catabolic process | 2.63% (2/76) | 7.2 | 7.8e-05 | 0.00867 |
GO:0009170 | purine deoxyribonucleoside monophosphate metabolic process | 2.63% (2/76) | 7.01 | 0.000104 | 0.008979 |
GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor | 2.63% (2/76) | 7.01 | 0.000104 | 0.008979 |
GO:0046098 | guanine metabolic process | 2.63% (2/76) | 7.01 | 0.000104 | 0.008979 |
GO:0050421 | nitrite reductase (NO-forming) activity | 2.63% (2/76) | 7.01 | 0.000104 | 0.008979 |
GO:0034465 | response to carbon monoxide | 2.63% (2/76) | 6.68 | 0.000166 | 0.010796 |
GO:0046121 | deoxyribonucleoside catabolic process | 2.63% (2/76) | 6.68 | 0.000166 | 0.010796 |
GO:0046122 | purine deoxyribonucleoside metabolic process | 2.63% (2/76) | 6.68 | 0.000166 | 0.010796 |
GO:0046124 | purine deoxyribonucleoside catabolic process | 2.63% (2/76) | 6.68 | 0.000166 | 0.010796 |
GO:0015115 | silicate transmembrane transporter activity | 2.63% (2/76) | 6.42 | 0.000243 | 0.011846 |
GO:0015708 | silicic acid import across plasma membrane | 2.63% (2/76) | 6.42 | 0.000243 | 0.011846 |
GO:0098658 | inorganic anion import across plasma membrane | 2.63% (2/76) | 6.42 | 0.000243 | 0.011846 |
GO:0000255 | allantoin metabolic process | 2.63% (2/76) | 6.42 | 0.000243 | 0.011846 |
GO:1901292 | nucleoside phosphate catabolic process | 5.26% (4/76) | 3.79 | 0.00021 | 0.012137 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 2.63% (2/76) | 6.55 | 0.000203 | 0.012165 |
GO:0098809 | nitrite reductase activity | 2.63% (2/76) | 6.55 | 0.000203 | 0.012165 |
GO:0140376 | innate immune receptor activity | 3.95% (3/76) | 6.27 | 8e-06 | 0.012258 |
GO:0006801 | superoxide metabolic process | 3.95% (3/76) | 4.86 | 0.000154 | 0.012659 |
GO:0006145 | purine nucleobase catabolic process | 2.63% (2/76) | 6.31 | 0.000287 | 0.012783 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 2.63% (2/76) | 6.31 | 0.000287 | 0.012783 |
GO:0097184 | response to azide | 2.63% (2/76) | 6.31 | 0.000287 | 0.012783 |
GO:0009166 | nucleotide catabolic process | 5.26% (4/76) | 3.88 | 0.000166 | 0.012906 |
GO:0034052 | positive regulation of plant-type hypersensitive response | 3.95% (3/76) | 4.66 | 0.000234 | 0.013051 |
GO:0046130 | purine ribonucleoside catabolic process | 2.63% (2/76) | 6.2 | 0.000334 | 0.014481 |
GO:0009128 | purine nucleoside monophosphate catabolic process | 2.63% (2/76) | 6.1 | 0.000385 | 0.015019 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 2.63% (2/76) | 6.1 | 0.000385 | 0.015019 |
GO:0042454 | ribonucleoside catabolic process | 2.63% (2/76) | 6.1 | 0.000385 | 0.015019 |
GO:0043546 | molybdopterin cofactor binding | 2.63% (2/76) | 6.1 | 0.000385 | 0.015019 |
GO:0015105 | arsenite transmembrane transporter activity | 2.63% (2/76) | 6.01 | 0.00044 | 0.016327 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 2.63% (2/76) | 6.01 | 0.00044 | 0.016327 |
GO:0010044 | response to aluminum ion | 3.95% (3/76) | 4.29 | 0.000502 | 0.017796 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 2.63% (2/76) | 5.92 | 0.000498 | 0.018051 |
GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor | 2.63% (2/76) | 5.84 | 0.000559 | 0.01938 |
GO:0009158 | ribonucleoside monophosphate catabolic process | 2.63% (2/76) | 5.76 | 0.000624 | 0.020281 |
GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors | 2.63% (2/76) | 5.76 | 0.000624 | 0.020281 |
GO:0046113 | nucleobase catabolic process | 2.63% (2/76) | 5.76 | 0.000624 | 0.020281 |
GO:0080135 | regulation of cellular response to stress | 9.21% (7/76) | 2.26 | 0.000647 | 0.020577 |
GO:0046715 | active borate transmembrane transporter activity | 2.63% (2/76) | 5.68 | 0.000693 | 0.021182 |
GO:0006152 | purine nucleoside catabolic process | 2.63% (2/76) | 5.68 | 0.000693 | 0.021182 |
GO:0009125 | nucleoside monophosphate catabolic process | 2.63% (2/76) | 5.61 | 0.000765 | 0.0225 |
GO:0010363 | regulation of plant-type hypersensitive response | 3.95% (3/76) | 4.08 | 0.000759 | 0.02275 |
GO:0015700 | arsenite transport | 2.63% (2/76) | 5.55 | 0.00084 | 0.02382 |
GO:0009164 | nucleoside catabolic process | 2.63% (2/76) | 5.55 | 0.00084 | 0.02382 |
GO:1902275 | regulation of chromatin organization | 3.95% (3/76) | 4.02 | 0.00086 | 0.023935 |
GO:0034656 | nucleobase-containing small molecule catabolic process | 2.63% (2/76) | 5.48 | 0.000919 | 0.024708 |
GO:0046386 | deoxyribose phosphate catabolic process | 2.63% (2/76) | 5.48 | 0.000919 | 0.024708 |
GO:0009120 | deoxyribonucleoside metabolic process | 2.63% (2/76) | 5.42 | 0.001002 | 0.026464 |
GO:0015204 | urea transmembrane transporter activity | 2.63% (2/76) | 5.36 | 0.001087 | 0.027787 |
GO:0009264 | deoxyribonucleotide catabolic process | 2.63% (2/76) | 5.36 | 0.001087 | 0.027787 |
GO:0015840 | urea transport | 2.63% (2/76) | 5.31 | 0.001176 | 0.028655 |
GO:0071347 | cellular response to interleukin-1 | 2.63% (2/76) | 5.31 | 0.001176 | 0.028655 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 2.63% (2/76) | 5.31 | 0.001176 | 0.028655 |
GO:0009154 | purine ribonucleotide catabolic process | 2.63% (2/76) | 5.25 | 0.001269 | 0.030433 |
GO:1903684 | regulation of border follicle cell migration | 2.63% (2/76) | 5.2 | 0.001365 | 0.031289 |
GO:1903688 | positive regulation of border follicle cell migration | 2.63% (2/76) | 5.2 | 0.001365 | 0.031289 |
GO:0015168 | glycerol transmembrane transporter activity | 2.63% (2/76) | 5.2 | 0.001365 | 0.031289 |
GO:0019755 | one-carbon compound transport | 2.63% (2/76) | 5.15 | 0.001464 | 0.033078 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 2.63% (2/76) | 5.1 | 0.001567 | 0.034399 |
GO:0046128 | purine ribonucleoside metabolic process | 2.63% (2/76) | 5.1 | 0.001567 | 0.034399 |
GO:0006195 | purine nucleotide catabolic process | 2.63% (2/76) | 5.01 | 0.001782 | 0.038052 |
GO:0009261 | ribonucleotide catabolic process | 2.63% (2/76) | 5.01 | 0.001782 | 0.038052 |
GO:0042393 | histone binding | 5.26% (4/76) | 2.95 | 0.001832 | 0.03808 |
GO:0043903 | regulation of biological process involved in symbiotic interaction | 3.95% (3/76) | 3.65 | 0.001808 | 0.038088 |
GO:0046434 | organophosphate catabolic process | 5.26% (4/76) | 2.91 | 0.002013 | 0.040758 |
GO:0015166 | polyol transmembrane transporter activity | 2.63% (2/76) | 4.92 | 0.00201 | 0.041236 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.63% (2/76) | 4.88 | 0.002129 | 0.042022 |
GO:0009119 | ribonucleoside metabolic process | 2.63% (2/76) | 4.88 | 0.002129 | 0.042022 |
GO:0080170 | hydrogen peroxide transmembrane transport | 2.63% (2/76) | 4.8 | 0.002378 | 0.04576 |
GO:0042803 | protein homodimerization activity | 10.53% (8/76) | 1.77 | 0.002356 | 0.045905 |
GO:0016328 | lateral plasma membrane | 2.63% (2/76) | 4.76 | 0.002506 | 0.047079 |
GO:0030856 | regulation of epithelial cell differentiation | 2.63% (2/76) | 4.76 | 0.002506 | 0.047079 |
GO:0006144 | purine nucleobase metabolic process | 2.63% (2/76) | 4.72 | 0.002639 | 0.048971 |
GO:0061849 | telomeric G-quadruplex DNA binding | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0009702 | L-arabinokinase activity | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0072702 | response to methyl methanesulfonate | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0002197 | xanthine dehydrogenase complex | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0034418 | urate biosynthetic process | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0045601 | regulation of endothelial cell differentiation | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0045602 | negative regulation of endothelial cell differentiation | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0070674 | hypoxanthine dehydrogenase activity | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0070675 | hypoxanthine oxidase activity | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:2001212 | regulation of vasculogenesis | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:2001213 | negative regulation of vasculogenesis | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0007419 | ventral cord development | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0045035 | sensory organ precursor cell division | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0046668 | regulation of retinal cell programmed cell death | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0046669 | regulation of compound eye retinal cell programmed cell death | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0046671 | negative regulation of retinal cell programmed cell death | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:0046673 | negative regulation of compound eye retinal cell programmed cell death | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1900117 | regulation of execution phase of apoptosis | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1900118 | negative regulation of execution phase of apoptosis | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |
GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | 1.32% (1/76) | 8.01 | 0.003885 | 0.049241 |